Sanofi top-lined positive clinical data today from its investigational basal insulin, as it seeks to defend its position in this fast-growing segment.
These 16 agents, hand-picked from a total field of 164, are poised for approval, and possibly much more. Marc Iskowitz reports
The AHA/ACC panel that wrote the potentially practice-changing cholesterol guidelines issued last month included six members with ties to drugmakers that sell or are developing lipid medications, Pharmalot reported.
News on Bayer Healthcare, Onyx Pharmaceuticals, Lilly, J&J, CMS and Community Care Behavioral Health Organization
News from Pfizer, the National Institute on Drug Abuse, HealthTap and LEO Pharma